Background Specific reversal agents for non–vitamin K antagonist oral anticoagulants are
lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant …

Background Intracerebral hemorrhage is the least treatable form of stroke and is associated
with high mortality. Among patients who undergo computed tomography (CT) within three …

Background Intracerebral hemorrhage is the least treatable form of stroke. We performed
this phase 3 trial to confirm a previous study in which recombinant activated factor VII (rFVIIa) …

Background: Intracranial aneurysm with and without subarachnoid haemorrhage (SAH) is a
relevant health problem: The overall incidence is about 9 per 100,000 with a wide range, in …

Background Idarucizumab, a monoclonal antibody fragment, was developed to reverse the
anticoagulant effect of dabigatran. Methods We performed a multicenter, prospective, open-…

Background Intracerebral hemorrhage (ICH) accounted for 9% to 27% of all strokes worldwide
in the last decade, with high early case fatality and poor functional outcome. In view of …

Background Limited data are available to guide the choice of a target for the systolic blood-pressure
level when treating acute hypertensive response in patients with intracerebral …

Background and Purpose—The term symptomatic hemorrhage secondary to ischemic
stroke implies a clear causal relationship between clinical deterioration and hemorrhagic …

… Steiner T , … Külkens S, Ringleb P, Diedler J, Hacke W, Steiner T … Jüttler E, Steiner T …

The original version of this consensus statement on mechanical thrombectomy was approved
at the European Stroke Organisation (ESO)-Karolinska Stroke Update conference in …